PureTech Health Balance Sheet Health
Financial Health criteria checks 3/6
PureTech Health has a total shareholder equity of $306.2M and total debt of $124.7M, which brings its debt-to-equity ratio to 40.7%. Its total assets and total liabilities are $580.0M and $273.7M respectively.
Key information
40.7%
Debt to equity ratio
US$124.74m
Debt
| Interest coverage ratio | n/a |
| Cash | US$500.42m |
| Equity | US$306.21m |
| Total liabilities | US$273.74m |
| Total assets | US$579.95m |
Recent financial health updates
Is PureTech Health (LON:PRTC) Using Debt Sensibly?
Nov 15
Is PureTech Health (LON:PRTC) A Risky Investment?
Apr 28Health Check: How Prudently Does PureTech Health (LON:PRTC) Use Debt?
Dec 21Is PureTech Health (LON:PRTC) Using Too Much Debt?
Aug 28Recent updates
Is PureTech Health (LON:PRTC) Using Debt Sensibly?
Nov 15What You Need To Know About The PureTech Health plc (LON:PRTC) Analyst Downgrade Today
Aug 27Is PureTech Health (LON:PRTC) A Risky Investment?
Apr 28Health Check: How Prudently Does PureTech Health (LON:PRTC) Use Debt?
Dec 21Is PureTech Health (LON:PRTC) Using Too Much Debt?
Aug 28PureTech Health plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 18Financial Position Analysis
Short Term Liabilities: PRTC's short term assets ($508.8M) exceed its short term liabilities ($138.3M).
Long Term Liabilities: PRTC's short term assets ($508.8M) exceed its long term liabilities ($135.4M).
Debt to Equity History and Analysis
Debt Level: PRTC has more cash than its total debt.
Reducing Debt: PRTC's debt to equity ratio has increased from 3.6% to 40.7% over the past 5 years.
Debt Coverage: PRTC's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if PRTC's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 06:39 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PureTech Health plc is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Welford | Jefferies LLC |
| Thomas Smith | Leerink Partners LLC |
| Faisal Khurshid | Leerink Partners LLC |